or
forgot password
  • cancer clinical trials in lansing, MI

  • Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Prostate Cancer
    S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Melanoma (Skin)
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Sparrow Regional Cancer Center

    Trial Locations
    Sparrow Regional Cancer Center
    Breslin Cancer Center at Ingham Regional Medical Center
    Breast Cancer
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Breast Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Sarcoma
    Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Lung Cancer
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Sparrow Regional Cancer Center

    Trial Locations
    Sparrow Regional Cancer Center
    Breslin Cancer Center at Ingham Regional Medical Center
    Lung Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Breast Cancer
    Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
    Sparrow Hospital
    Lansing, Michigan 48912
    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Esophageal Cancer, Gastric Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Sparrow Regional Cancer Center

    Trial Locations
    Sparrow Regional Cancer Center
    Breslin Cancer Center at Ingham Regional Medical Center
    Breast Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Endometrial Cancer
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Sparrow Hospital
    Lansing, Michigan 48912
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Sparrow Regional Cancer Center

    Trial Locations
    Sparrow Regional Cancer Center
    Breslin Cancer Center at Ingham Regional Medical Center
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Ingham Regional Medical Center

    Trial Locations
    Ingham Regional Medical Center
    Sparrow Hospital
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Brain Tumor, Central Nervous System Tumor
    Ixabepilone in Treating Patients With Metastatic Prostate Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Prostate Cancer
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Kidney Cancer
    Bortezomib, Paclitaxel, and Carboplatin Combined With Radiation Therapy in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    Sparrow Hospital
    Lansing, Michigan 48912
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Sparrow Regional Cancer Center

    Trial Locations
    Sparrow Regional Cancer Center
    Breslin Cancer Center at Ingham Regional Medical Center
    Colorectal Cancer
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Sparrow Hospital
    Lansing, Michigan 48912
    Recurrent Mantle Cell Lymphoma
    Temozolomide and Radiation Therapy in Treating Patients With Gliomas
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Brain and Central Nervous System Tumors
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Breast Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Ingham Regional Medical Center

    Trial Locations
    Ingham Regional Medical Center
    Sparrow Hospital
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Sparrow Hospital
    Lansing, Michigan 48912
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Breast Cancer, Cognitive/Functional Effects, Colorectal Cancer, Lung Cancer, Pain, Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Sparrow Regional Cancer Center
    Lansing, Michigan 48912-1811
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Ingham Regional Medical Center

    Trial Locations
    Ingham Regional Medical Center
    Sparrow Hospital
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Great Lakes Cancer Institute
    Lansing, Michigan 48910
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Sparrow Hospital
    Lansing, Michigan 48912
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
    Sparrow Hospital
    Lansing, Michigan 48912
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Kidney Cancer
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Sparrow Hospital
    Lansing, Michigan 48912
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Sparrow Hospital
    Lansing, Michigan 48912
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Leukemia, Myelodysplastic Syndromes
    Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
    Breslin Cancer Center at Ingham Regional Medical Center
    Lansing, Michigan 48910
    Leukemia